Tumor Embolization Devices Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

The Tumor Embolization Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Tumor Embolization Devices Market?
The tumor embolization devices market has shown strong growth, expected to increase from $1493.6 billion in 2024 to $1600.57 billion in 2025, with a CAGR of 7.2%. The growth is driven by technological advancements, the rise in cancer cases, the aging population, and the popularity of minimally invasive procedures.

The tumor embolization devices market is projected to grow strongly, reaching $2286.1 billion by 2029 at a CAGR of 9.3%. Growth is driven by personalized medicine, combination therapies, image-guided embolization techniques, and the rise of telemedicine. Major trends include innovations in embolic agents, transarterial chemoembolization (TACE), the use of embolization in palliative care, and image-guided procedures.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352

What Are the Different Tumor Embolization Devices Market Segments?
The tumor embolization devices market covered in this report is segmented -

1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers

Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol - PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp

What Are the Primary Drivers Shaping the Tumor Embolization Devices Market?
The global increase in cancer cases is also driving the tumor embolization devices market. According to Macmillan Cancer Support, the number of cancer patients in the UK is expected to reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. This upward trend in incidence is expected to boost market demand.

Which Companies Are Leading in the Tumor Embolization Devices Market?
Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

What Trends Are Expected to Dominate the Tumor Embolization Devices Market in the Next 5 Years?
In the tumor embolization devices market, companies are enhancing the accuracy of tumor-targeted treatments with innovations like angiography systems. Siemens Healthineers introduced the Artis Icono Ceiling in June 2022, which captures rapid 3D images to improve precision during tumor embolization and reduce the need for contrast media.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

What Are the Top Revenue-Generating Geographies in the Tumor Embolization Devices Market?
North America was the largest region in the tumor embolization devices market in 2023. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Tumor Embolization Devices Market?
2. What is the CAGR expected in the Tumor Embolization Devices Market?
3. What Are the Key Innovations Transforming the Tumor Embolization Devices Industry?
4. Which Region Is Leading the Tumor Embolization Devices Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.